Animal Pharmaceuticals Market by Type (Vaccine, Veterinary Drugs), Product (Anti-Inflammatories, Bronchodilators, Ectoparasiticides), Application, End User - Global Forecast 2024-2030
Animal Pharmaceuticals Market by Type (Vaccine, Veterinary Drugs), Product (Anti-Inflammatories, Bronchodilators, Ectoparasiticides), Application, End User - Global Forecast 2024-2030
The Animal Pharmaceuticals Market size was estimated at USD 20.54 billion in 2023 and expected to reach USD 22.17 billion in 2024, at a CAGR 8.01% to reach USD 35.24 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Animal Pharmaceuticals Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Animal Pharmaceuticals Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Animal Pharmaceuticals Market, highlighting leading vendors and their innovative profiles. These include Aratana Therapeutics, Inc. by Elanco Animal Health Inc., Boehringer Ingelheim International GmbH, Dechra Pharmaceuticals PLC, Hester Biosciences Limited, Huvepharma, Inc., Indian Immunologicals Ltd., Merck & Co., Inc., Neogen Corp., Nutreco N.V., Perrigo Company plc, Sanofi-Aventis Groupe S.A., Vesper Group, Vetoquinol S.A., Virbac S.A., and Zoetis Inc..
Market Segmentation & Coverage
This research report categorizes the Animal Pharmaceuticals Market to forecast the revenues and analyze trends in each of the following sub-markets:
Type
Vaccine
Veterinary Drugs
Product
Anti-Inflammatories
Bronchodilators
Ectoparasiticides
Endoparasiticides
Application
Companion Animal
Poultry
End User
Hospitals
Laboratories
Veternary Clinics
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom The report offers valuable insights on the following aspects:
Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
What is the market size and forecast of the Animal Pharmaceuticals Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Animal Pharmaceuticals Market?
What are the technology trends and regulatory frameworks in the Animal Pharmaceuticals Market?
What is the market share of the leading vendors in the Animal Pharmaceuticals Market?
Which modes and strategic moves are suitable for entering the Animal Pharmaceuticals Market?
Note: PDF & Excel + Online Access - 1 Year
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Animal Pharmaceuticals Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising adoption of pets coupled with growing cases of zoonotic and chronic diseases
5.1.1.2. Rapid growth experienced in livestock population
5.1.1.3. Emergence of government mandatory medication and vaccinations
5.1.2. Restraints
5.1.2.1. Limited awareness and availability
5.1.3. Opportunities
5.1.3.1. Increasing awareness and expenditure among people regarding animal healthcare
5.1.3.2. Development of new broad range of products for companion animals with new combinations
5.1.4. Challenges
5.1.4.1. Several risk factors associated with animal health APIs
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Animal Pharmaceuticals Market, by Type
6.1. Introduction
6.2. Vaccine
6.3. Veterinary Drugs
7. Animal Pharmaceuticals Market, by Product
7.1. Introduction
7.2. Anti-Inflammatories
7.3. Bronchodilators
7.4. Ectoparasiticides
7.5. Endoparasiticides
8. Animal Pharmaceuticals Market, by Application
8.1. Introduction
8.2. Companion Animal
8.3. Poultry
9. Animal Pharmaceuticals Market, by End User
9.1. Introduction
9.2. Hospitals
9.3. Laboratories
9.4. Veternary Clinics
10. Americas Animal Pharmaceuticals Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Animal Pharmaceuticals Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Animal Pharmaceuticals Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Aratana Therapeutics, Inc. by Elanco Animal Health Inc.
14.1.2. Boehringer Ingelheim International GmbH
14.1.3. Dechra Pharmaceuticals PLC
14.1.4. Hester Biosciences Limited
14.1.5. Huvepharma, Inc.
14.1.6. Indian Immunologicals Ltd.
14.1.7. Merck & Co., Inc.
14.1.8. Neogen Corp.
14.1.9. Nutreco N.V.
14.1.10. Perrigo Company plc
14.1.11. Sanofi-Aventis Groupe S.A.
14.1.12. Vesper Group
14.1.13. Vetoquinol S.A.
14.1.14. Virbac S.A.
14.1.15. Zoetis Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. ANIMAL PHARMACEUTICALS MARKET RESEARCH PROCESS
FIGURE 2. ANIMAL PHARMACEUTICALS MARKET SIZE, 2023 VS 2030